Dynamic single-cell analysis instrument to evaluate immune cell function
- Institution
- CELLCHORUS INC., TX
- Principal investigator
- Laurence J.N. Cooper
- Funding
- $56K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
The goal of this Fast-Track SBIR is to manufacture Chronos: a dedicated instrument for image- based dynamic, functional single-cell analysis for use with the CellChorus® TIMING™ (Time- Lapse Imaging Microscopy In Nanowell Grids) platform. The TIMING technological platform is also being validated by academic and commercial entities through peer-reviewed publications, presentations, and commercial contracts through the CellChorus Early Access Program, including new abstracts and publications by CellChorus and the lab from which we spun out. Importantly, a recent publication in Nature Cancer shows that TIMING can be used to identify the most potent cytolytic CAR T cells among populations of infusion products (Rezvan et al, Nat Cancer 2024). TIMING encompasses 1) plating cells in nanowells arrayed in grids of 5,000-10,000 nanowells; 2) rapid and gentle time-lapse imaging over hours with multiple light channels; and 3) AI-powered analysis of cell behaviors. This project addresses the second part of the platform (2) by creation of Chronos, an enclosed imager with the key features needed for users to very easily run TIMING assays without needing advanced microscopy training.
LOADING MOONBASE SCORE
Questions for Cellchorus Inc.
Cellchorus Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cellchorus Inc.Not yet scored
Dynamic single-cell analysis instrument to evaluate immune cell function
Laurence J.N. Cooper · $463K · 2023–2026
- NIH · Cellchorus Inc.Not yet scored
Functional signatures of post-infusion CAR T cells for early indication of patient response
Rebecca L Berdeaux · $400K · 2025–2026
- NIH · Cellchorus Inc.Not yet scored
LF-TIMING: Large-scale label-free profiling of cell-cell interactions
Rebecca L Berdeaux · $1.1M · 2024–2027